Oral surveillance and JAK inhibitor safety: the theory of relativity | Nature Reviews Rheumatology
JAK Inhibitors Are Coming and They Are the Biggest Eczema Development in Years | National Eczema Association
First alopecia treatment for autoimmune disorder that causes sudden hair loss approved by the FDA
The role of JAK/STAT signalling in the pathogenesis, prognosis and treatment of solid tumours | British Journal of Cancer
FDA approves new therapy for people living with skin-discoloration disorder vitiligo - ABC News
New Drug Helps Some Bald Patients Regrow Hair - The New York Times
Efficacy of JAK 1/2 inhibition in the treatment of diffuse non-scarring alopecia due to systemic lupus erythematosus | Annals of the Rheumatic Diseases
Janus kinase (JAK) inhibitors in the treatment of inflammatory and neoplastic diseases - ScienceDirect
Alopecia areata treatment: a role involving Janus Kinase (JAK) inhibitors
:max_bytes(150000):strip_icc()/jak-inhibitors-4706526-FINAL-3461d4fc6ce44f54801ef59489afa62c.png "JAK Inhibitors: Uses, Drug Options, and Side Effects")
JAK Inhibitors: Uses, Drug Options, and Side Effects
Are JAK Inhibitors the Same as Biologic Drugs? No, Here's Why - GoodRx
Pharmacologic inhibition of JAK-STAT signaling promotes hair growth | Science Advances
Rheumatoid arthritis | JAK inhibitors: The next generation of drugs for treating rheumatoid arthritis? | rheumatology.medicinematters.com
Treating sarcoidosis with JAK inhibitor shows promise in clinical trial | YaleNews
Cells | Free Full-Text | Small Molecule Inhibitors in the Treatment of Rheumatoid Arthritis and Beyond: Latest Updates and Potential Strategy for Fighting COVID-19
Jak Inhibitor: The New Treatment Option For Those With Hair Loss
Frontiers | Janus Kinase Inhibitors in the Treatment of Vitiligo: A Review
Discovery of a Gut-Restricted JAK Inhibitor for the Treatment of Inflammatory Bowel Disease | Journal of Medicinal Chemistry
Targeting the JAK-STAT pathway in the treatment of 'Th2-high' severe asthma | Future Medicinal Chemistry
The Potential of JAK/STAT Pathway Inhibition as a New Treatment Strategy to Control Cytokine Release Syndrome in COVID-19 | Biological and Medicinal Chemistry | ChemRxiv | Cambridge Open Engage
Frontiers | Emerging Topical and Systemic JAK Inhibitors in Dermatology
The potential of JAK/STAT pathway inhibition by ruxolitinib in the treatment of COVID-19 - ScienceDirect
Consumer's Guide to JAK Inhibitors for Psoriatic Arthritis | Everyday Health
Phytochemicals targeting JAK/STAT pathway in the treatment of rheumatoid arthritis: Is there a future? - ScienceDirect
Jakinibs for Rheumatoid Arthritis Treatment
Topical JAK inhibitor - An effective treatment for facial vitiligo
